Post-operative radioactive iodine administration in patients with low-risk thyroid cancer

Article Endocrinology & Metabolism

Trends in the Management of Localized Papillary Thyroid Carcinoma in the United States (2000-2018)

Elisa Pasqual et al.

Summary: The use of radioactive iodine (RAI) in the management of low-risk adult and pediatric papillary thyroid carcinoma (PTC) has decreased in line with changing recommendations. The use of total thyroidectomy has increased, while the use of lobectomy has shown more subtle changes. These treatment trends were observed across different demographics. The importance of these trends in low-risk PTC management after 2015 remains uncertain.

THYROID (2022)

Add to Collection

Editorial Material Medicine, General & Internal

Thyroidectomy without radioiodine therapy

Susanne Krome

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2022)

Add to Collection

Review Endocrinology & Metabolism

Serum Thyroglobulin Measurement Following Surgery Without Radioactive Iodine for Differentiated Thyroid Cancer: A Systematic Review

Roger Chou et al.

Summary: This systematic review examines the diagnostic accuracy of serum thyroglobulin (Tg) measurement for differentiated thyroid cancer in situations of partial thyroidectomy or total/near-total thyroidectomy without or before radioactive iodine (RAI) treatment. The review finds limited evidence suggesting low utility of Tg measurement for identifying recurrent or metastatic disease following partial thyroidectomy. After total/near-total thyroidectomy without RAI, Tg levels using a cutoff of 1-2.5 ng/mL might identify patients at low risk for persistent or metastatic disease. However, further research is needed to clarify the role of Tg measurement in these settings.

THYROID (2022)

Add to Collection

Article Medicine, General & Internal

Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer

S. Leboulleux et al.

Summary: In patients with low-risk differentiated thyroid cancer undergoing thyroidectomy, a follow-up strategy without the use of radioiodine is noninferior to an ablation strategy with radioiodine in terms of functional, structural, and biologic events at 3 years.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Article Endocrinology & Metabolism